相似文献
1
The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.
Cells. 2024 Oct 12;13(20):1688. doi: 10.3390/cells13201688.
2
Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Am J Clin Dermatol. 2008;9(1):15-31. doi: 10.2165/00128071-200809010-00002.
3
Biology and therapeutic applications of peroxisome proliferator- activated receptors.
Curr Top Med Chem. 2012;12(6):548-84. doi: 10.2174/156802612799436669.
4
Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
Fundam Clin Pharmacol. 2007 Jun;21(3):231-44. doi: 10.1111/j.1472-8206.2007.00486.x.
5
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases.
Front Pharmacol. 2020 May 27;11:730. doi: 10.3389/fphar.2020.00730. eCollection 2020.
6
The role of peroxisome proliferator-activated receptors (PPAR) in immune responses.
Metabolism. 2021 Jan;114:154338. doi: 10.1016/j.metabol.2020.154338. Epub 2020 Aug 11.
7
Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases.
Int Immunopharmacol. 2025 May 16;155:114616. doi: 10.1016/j.intimp.2025.114616. Epub 2025 Apr 13.
8
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):145-56. doi: 10.1038/ncpendmet0397.
9
Kinase signaling cascades that modulate peroxisome proliferator-activated receptors.
Curr Opin Cell Biol. 2005 Apr;17(2):216-22. doi: 10.1016/j.ceb.2005.02.002.
10
The Role of PPARs in Disease.
Cells. 2020 Oct 28;9(11):2367. doi: 10.3390/cells9112367.
本文引用的文献
1
PPARβ/δ-orchestrated metabolic reprogramming supports the formation and maintenance of memory CD8 T cells.
Sci Immunol. 2024 Aug 23;9(98):eadn2717. doi: 10.1126/sciimmunol.adn2717.
2
Apigenin: A Bioflavonoid with a Promising Role in Disease Prevention and Treatment.
Biomedicines. 2024 Jun 18;12(6):1353. doi: 10.3390/biomedicines12061353.
3
Exploring Impact of Probiotic-Fermented Soymilk on Dextran-Sulfate-Sodium-Induced Ulcerative Colitis via Modulating Inflammation and Gut Microbiota Profile.
Mol Nutr Food Res. 2024 Mar;68(5):e2300586. doi: 10.1002/mnfr.202300586. Epub 2024 Feb 1.
4
Effects of polyphenolic maqui () extract on the inhibition of NLRP3 inflammasome and activation of mast cells in a mouse model of Crohn's disease-like colitis.
Front Immunol. 2024 Jan 12;14:1229767. doi: 10.3389/fimmu.2023.1229767. eCollection 2023.
5
Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression.
Clin Nutr. 2024 Feb;43(2):332-345. doi: 10.1016/j.clnu.2023.12.005. Epub 2023 Dec 9.
6
Resveratrol and Gut Microbiota Synergy: Preventive and Therapeutic Effects.
Int J Mol Sci. 2023 Dec 17;24(24):17573. doi: 10.3390/ijms242417573.
7
A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells.
Sci Rep. 2023 Nov 3;13(1):18983. doi: 10.1038/s41598-023-46404-5.
8
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases.
Int J Mol Sci. 2023 Oct 13;24(20):15165. doi: 10.3390/ijms242015165.
9
Dupilumab Can Induce Remission of Eosinophilic Gastritis and Duodenitis: A Retrospective Case Series.
Clin Transl Gastroenterol. 2024 Jan 1;15(1):e00646. doi: 10.14309/ctg.0000000000000646.
10
cDC1 craves glutamine for its glory.
Nat Immunol. 2023 Sep;24(9):1405-1406. doi: 10.1038/s41590-023-01598-8.
Zotero 插件